Phone: (206) 616-4482
AboutPrescription opioids are posing a substantial and growing health care problem as well, with an estimated 2.1 million people in the U.S. suffering from substance use disorders related to prescription opioid pain relievers in 2012. A greater availability of opioid prescribed drugs has been accompanied by alarming increases in the estimated number of overdose deaths due to these pain relievers, which have more than tripled in the past 20 years. Our collaborative research is testing strategies to support primary care practice change that can lower the risks of death and drug overdose among patients who are taking opioid medications for chronic non-cancer pain. Tobacco use continues to be the leading cause of disease, disability, and death in the US and the world, killing 480,000 people per year in the US and nearly 6 million globally. While tobacco prevention policies and programs have reduced overall prevalence of tobacco use in developed countries, health disparities have increased among disadvantaged populations, and tobacco-related disease and death in low-resource countries is rising. Helping people quit smoking and reducing involuntary exposure to secondhand smoke are the fastest and most effective ways to reduce the toll of the tobacco epidemic, locally, nationally and globally.
Team-Based Safe Opioid Prescribing: Collaborating with remote rural practices to study the implementation of best practices for managing chronic opioid therapy among patients with non-cancer pain
UW Tobacco Studies Program:
(TSP) provides training for future tobacco control leaders, including graduate students, clinicians and public health practitioners, to develop the knowledge and skills needed to prevent and treat tobacco addiction, through education, research, health policy, and program development.
The International Quitline Institute:
(IQI), in partnership with the World Health Organization (WHO), addresses article 14 of the FCTC by expanding access to evidence-based treatment through training and development of telephone quit lines, and integration with public health and health care systems in low and middle-income countries.
- Grande L, Delacruz H, Thompson M, Terman G, Rosenblatt R. (417) Oral ketamine for chronic pain: a 32-subject placebo-controlled trial in patients on chronic opioids.. J Pain. Apr 2016
- Cerimele JM, Halperin AC, Saxon AJ. Tobacco use treatment in primary care patients with psychiatric illness.. J Am Board Fam Med.
- Metzger MJ, Halperin AC, Manhart LE, Hawes SE. Association of maternal smoking during pregnancy with infant hospitalization and mortality due to infectious diseases.. Pediatr. Infect. Dis. J.. Jan 2013
- Tran BT, Halperin A, Chien JW. Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation.. Biol. Blood Marrow Transplant.. Jul 2011
- Halperin AC, McAfee TA, Jack LM, Catz SL, McClure JB, Deprey TM, Richards J, Zbikowski SM, Swan GE. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.. J Subst Abuse Treat. Jun 2009
- Halperin AC, Thompson LA, Hymer JC, Peterson AK, Thompson B. A case-based clinician training program for treating tobacco use in college students.. Public Health Rep.
- Savage SE, Halperin AC. Building an academic tobacco control program while forging links with practice: the University of Washington Tobacco Studies Program.. Public Health Rep.
- Carlini BH, Patrick DL, Halperin AC, Santos V. The tobacco industry's response to the COMMIT Trial: an analysis of legacy tobacco documents.. Public Health Rep.
- Halperin AC, Rigotti NA. US public universities' compliance with recommended tobacco-control policies.. J Am Coll Health. Mar 2003